BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Feedo Feed//NONSGML v1.0//EN
METHOD:PUBLISH
X-WR-CALNAME:BioArbor: Driving a Genomics Revolution through Open Source Innovation at 2800 Plymouth Rd., Ann Arbor, MI - Meetings on Plancast
X-WR-CALDESC:Presented by BioArbor Life Science Forum and the University of Michigan Medical School Location:                              U of...
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VTIMEZONE
TZID:UTC
X-LIC-LOCATION:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
DTSTART:19700101T020000
RRULE:FREQ=YEARLY;BYMONTH=1;BYDAY=1TH
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20120606T170000Z
DTEND;TZID=UTC:20120606T170000Z
UID:a539594@plancast.com
SUMMARY:BioArbor: Driving a Genomics Revolution through Open Source
 Innovation
DESCRIPTION:Presented by BioArbor Life Science Forum and the University of
 Michigan Medical School Location:                 
             U of M North Campus Research Complex Bldg 18
 CafeteriaDate:                              
       Wed June 6\, 2012\, 5-7:30 PMNetworking & Reception:  
 5:00PM Speaker and Q&A:               6:00PM The
 promise of genomics gives humankind the hope of unprecedented
 future biomedical innovations.  But the pace of biomedical
 innovation has slowed down dramatically\, even as our
 understanding of fundamental disease biology and ability to
 capture data at the molecular/genomic level has increased
 exponentially.  There has been an increasing call to action to
 move to novel partnerships and open source models of innovation\,
 where multiple parties in both the private and public sectors
 collaborate\, early stage discoveries benefit from shared
 knowledge and datasets\, and innovations can incubate in a
 pre-competitive space.  The idea of sharing risks and rewards to
 better the welfare of humankind is certainly inviting\, but is it
 really possible to navigate across various stakeholder interests
 and collaborate effectively?  And when the next “big idea”
 comes are the benefits shared?  Come and hear the experiences of
 Eric Schadt\, a renowned pioneer in driving new models of
 innovation\, co-founder of Sage Bionetworks\, Director of the
 Institute for Genomics and Multiscale Biology\, and Chair of the
 Dept. of Genetics and Genomics Sciences at Mt. Sinai Medical
 School\, followed by a provocative conversation between Dr.
 Schadt and Dr. Brian Athey\, moderated by Connie Chang\, Director
 of U-M Medical School Business Development. Eric Schadt\,
 Ph.D.\, is Director of the Institute for Genomics and Multiscale
 Biology\, Chair of the Department of Genetics and Genomics
 Sciences and the Jean C. and James W. Crystal Professor of
 Genomics at the Mt. Sinai Medical School. Dr. Schadt is an expert
 on the generation and integration of very large-scale sequence
 variation\, molecular profiling and clinical data in disease
 populations for constructing molecular networks that define
 disease states and link molecular biology to physiology. His
 research has provided novel insights into what is needed to
 master diverse\, large-scale data collected on normal and disease
 populations in order to elucidate the complexity of disease and
 make more informed decisions in the drug discovery arena.  He
 has contributed to a number of discoveries relating to the
 genetic basis of common human diseases such as diabetes and
 obesity\, which have been widely published in leading scientific
 journals. Dr. Schadt is also a founding member of Sage
 Bionetworks\, an open-access genomics initiative designed to
 build and support databases and an accessible platform for
 creating innovative dynamic disease models. Prior to joining
 Pacific Biosciences in 2009\, he was Executive Scientific
 Director of Genetics at Rosetta Inpharmatics\, a subsidiary of
 Merck & Co.\, Inc. in Seattle\, and before Rosetta\, Dr. Schadt
 was a Senior Research Scientist at Roche Bioscience.  He
 received his B.A. in applied mathematics and computer science
 from California Polytechnic State University\, his M.A. in pure
 mathematics and his Ph.D. in bio-mathematics from University of
 California\, Los Angeles.  Brian D. Athey\, Ph.D.\, is Professor
 and Chair of the new Department of Computational Medicine and
 Bioinformatics at the University of Michigan Medical School.
 Prioer to this appointment he served as overall Director of
 Academic Informatics and Information Technology of the School. He
 is also the Principal Investigator of the U-M NIH/NIGMS
 Bioinformatics Training Grant. Trained as a biophysicist\, Dr.
 Athey is now recognized as one of the nation’s experts in the
 new field of ‘Translational Bioinformatics’ and also research
 cyberinfrastructure. He is chairman of a new venture in
 open-source technology called tranSMART\, a spinout informatics
 analysis and data sharing platform from Johnson & Johnson. In the
 mid-1980s\, Dr. Athey and his thesis mentor John Lagmore proposed
 the double helical crossed-linker model for the structure of
 chromatin\, once quite controversial\, it is now generally
 accepted. Brian established the first nationwide Internet2
 Visible Human Project demonstration under contract with the
 National Library of Medicine (NLM)\, was Principal Investigator
 of the DARPA Virtual Soldier Project\, and he currently leads the
 NIH National Center for Integrative Biomedical Informatics
 (NCIBI.org)\, one of eight NIH Roadmap Centers for Biomedical
 Computing. Dr. Athey is also Associate Director of Informatics
 and IT in the Michigan Institute for Clinical and Health
 Research\, home of the U-M CTSA\, and has served as national
 co-chair of the Clinical and Translational Sciences Award (CTSA)
 Informatics Key Function Committee (IKFC). Dr. Athey is a special
 advisor to the Chief Information Officer and Director of the
 Center for Information Technology (CIT) of the NIH. In 2000\, Dr.
 Athey was named a Peace Fellow of the Federation of American
 Scientists (FAS.org) for his work in the 1990s to combat
 biological warfare and terrorism. He is a founder and chairman of
 the board of the Washington\, DC\, based Scientists and Engineers
 for America (SEA.org). Connie Chang is the Director of Business
 Development for the University of Michigan Medical School\, a
 team she formed in 2010.  In this role Connie leads efforts in
 business development between the medical school research
 enterprise and external partners.  She joined the University of
 Michigan in 2009 after a 15-year career in business in Boston and
 New York\, including 12 years of experience in the
 pharmaceuticals industry where she worked in the commercial and
 marketing business functions.  Connie has a Bachelor of Arts
 degree in psychobiology from Harvard University and a Master in
 Business Administration from Harvard Business School.About Sage
 Bionetworks: The Sage Bionetworks Commons is an open source
 computational environment being developed to share mega-datasets
 and advanced tools in order to facilitate cooperative
 compilation\, comparison and evaluation of network models of
 disease. A set of Principles was developed at the 2011 Commons
 Congress to communicate the vision and to guide the behavior of
 those working in the Commons.\n
 When: Wednesday\, June 6\, 2012 from 5:00 PM to 7:30 PM\n
 Where: U-M North Campus Reasearch Complex - Bldg 18\n
 Attendees: 1 http://plancast.com/p/bkcq
URL:http://plancast.com/p/bkcq
CATEGORIES:Meetings,Sales
LOCATION:U-M North Campus Reasearch Complex - Bldg 18
DTSTAMP:20120525T042713Z
END:VEVENT
END:VCALENDAR